Indication
To improve wakefulness and reduce excessive daytime sleepiness (EDS) in adult patients with narcolepsy (with or without cataplexy).
Medicine details
- Medicine name:
- solriamfetol (Sunosi)
- SMC ID:
- SMC2439
- Pharmaceutical company
- Jazz Pharmaceuticals
- BNF chapter
- Central nervous system
- Submission type
- Full
- Publication due date:
- 11 July 2022
- SMC meeting date:
- 07 June 2022
- Patient group submission deadline:
- 04 April 2022